Retinoic acid binding protein in normal and neoplastic rat prostate

Mark S. Gesell, Martin J. Brandes, Eugene A. Arnold, J. T. Isaacs, Hisako Ueda, Juan C. Millan, David Brandes

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


Sucrose density gradient analysis of cytosol from normal and neoplastic rat prostatic tissues exhibited a peak of (3H) retinoic acid binding in the 2S region, corresponding to the cytoplasmic retinoic acid binding protein (cRABP). In the Fisher‐Copenhagen FI rat, cRABP was present in the lateral lobe, but could not be detected in the ventral nor in the dorsal prostatic lobes. Four sublines of the R‐3327 rat prostatic tumor contained similar levels of this binding protein. The absence of cRABP in the normal tissue of origin of the R‐3327 tumor, the rat dorsal prostate, and reappearance in the neoplastic tissues follows a pattern described in other human and animal tumors. The occurrence of cRABP in the well‐differentiated as well as in the anaplastic R‐3327 tumors in which markers which reflect a state of differentiation and hormonal regulation, such as androgen receptor, 5a reductase, and secretory acid phosphatase are either markedly reduced or absent, points to cRABP as a marker of malignant transformation.

Original languageEnglish (US)
Pages (from-to)131-138
Number of pages8
JournalThe Prostate
Issue number2
StatePublished - 1982


  • R‐3327 prostatic tumor
  • prostate
  • retinoic acid binding protein
  • transformation marker

ASJC Scopus subject areas

  • Oncology
  • Urology


Dive into the research topics of 'Retinoic acid binding protein in normal and neoplastic rat prostate'. Together they form a unique fingerprint.

Cite this